Quoin Pharmaceuticals Ltd.
13F holders, Q1 2024 (March 31)8holders
2famous investors
$0.94avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Quoin Pharmaceuticals Ltd. in their 13F filings. The largest holders were Altium Capital Management LLC ($63K), Renaissance Technologies ($44K) and Virtu Financial LLC ($29K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quoin Pharmaceuticals Ltd.
- CUSIP
- 74907L300
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $180K |
| Exits | 2 | $101K |
Ownership 8 holders
| Altium Capital Management LLC | 0.03% | New | 66,240 | $63K |
| Renaissance Technologies | 0.00% | New | 46,513 | $44K |
| Virtu Financial LLC | 0.00% | New | 30,749 | $29K |
| HRT Financial LP | 0.00% | New | 30,314 | $28K |
| Citadel Advisors | 0.00% | New | 10,786 | $10K |
| UBS Group AG | 0.00% | New | 5,105 | $5K |
| Rhumbline Advisers | 0.00% | Add +257.4% | 3,799 | $4K |
| JPMorgan Chase & Co. | 0.00% | New | 645 | $612 |
"% of holder's portfolio" is QUOIN PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Quoin Pharmaceuticals Ltd. the manager owns.